EichorEICHOR
Study identifier: NCT07696338 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Not Yet Recruiting

Rethinking Early Airway Clearence Therapies

Condition: Cystic Fibrosis (CF)  ·  Sponsor: Nicole Hamblett

PhaseNA
Planned participants405
Who can joinAll sexes, 3 Years to 16 Years
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

The REACT trial consists of two parallel, randomized studies; the Hypertonic Saline Study and the Dornase Alfa Study. Health outcomes among people with cystic fibrosis (CF) have been steadily improving, most recently with the advent of highly effective modulator therapy (HEMT). While therapies like hypertonic saline (HS) and dornase alfa (DA) improved outcomes in the past, they are often burdensome. Now that almost 90% of the North American CF population is being treated with elexacaftor/tezacaftor/ivacaftor (ETI) or vanzacaftor/tezacaftor/deutivacaftor (VTD), this trial will evaluate whether these newer treatments make daily HS or DA unnecessary. The trial begins with a 6-week run-in period where participants continue ETI or VTD but stop using HS and DA. Eligible participants are then assigned to either the HS Study or the DA Study for one year. Within those groups, they are randomized to either daily use of HS or DA or as needed use only during respiratory illnesses. The study aims to find out if lung health is similar between children and teens taking HEMT who use HS or DA treatments daily and those who use HS or DA treatments only when they are sick.

This description comes directly from the study's public registry record.

Talk to the study team

Rachael Buckingham  ·  206-884-7517  ·  rachael.buckingham@seattlechildrens.org

Anna Mead  ·  anna.mead@seattlechildrens.org

Always discuss trial participation with your own doctor first.

Locations (39)

The Children's Hospital Alabama, University of Alabama at BirminghamBirmingham, Alabama, United States
Tucson Cystic Fibrosis CenterTucson, Arizona, United States
Childrens Hospital Los AngelesLos Angeles, California, United States
CHOC Children's HospitalOrange, California, United States
Stanford University Medical CenterPalo Alto, California, United States
Children's Hospital ColoradoAurora, Colorado, United States
All Children's HospitalSt. Petersburg, Florida, United States
Children's Healthcare of Atlanta and Emory UniversityAtlanta, Georgia, United States
Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, Illinois, United States
Riley Hospital for ChildrenIndianapolis, Indiana, United States
University of IowaIowa City, Iowa, United States
John Hopkins HospitalBaltimore, Maryland, United States

+ 27 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →